StockNews.AI
CERE
StockNews.AI
122 days

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics

1. A class action lawsuit filed against CERE reveals potential legal issues. 2. Investors claim significant losses linked to securities law violations.

3m saved
Insight
Article

FAQ

Why Very Bearish?

Legal challenges typically lead to negative investor sentiment. Similar cases, such as those involving biotech firms like Athenex, led to sharp stock price declines.

How important is it?

Legal issues can significantly impact a company's market standing and investor confidence. Thus, they warrant high importance in assessing CERE's future stock performance.

Why Short Term?

Legal proceedings often exert immediate pressure on stock prices, especially in public perception.

Related Companies

PFEABBV
NEW YORK, NY / ACCESS Newswire / April 19, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him Directly To Discuss Their Options A class action was filed against against Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company"), Bain Capital Investors, LLC ("Bain") and Pfizer, Inc. ("Pfizer") on behalf of investors that (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive, and thus were damaged by defendants' violations of Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act"); (b) held shares of Cerevel as of January 8, 2024 (the "Record Date") and were entitled to vote on the merger of Cerevel and AbbVie Inc. ("AbbVie") and thus were damaged by defendants' violations of Section 14(a) of the Exchange Act; and/or (c) sold shares of Cerevel stock contemporaneously with Bain's purchase of shares on or about October 16, 2023 and thus were damaged by Bain's violations of Section 20A of the Exchange Act. If you would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.

Related News